194 results
8-K
EX-2.1
HGENQ
Humanigen, Inc
8 Jan 24
Entry into a Material Definitive Agreement
5:02pm
). At the request of Seller, no more than once each calendar year (following the end of any Annual Net Sales Period), Purchaser shall permit an independent … by Purchaser.
(a) Purchaser acknowledges and agrees that it has conducted to its full satisfaction an independent investigation and verification
NT 10-Q
HGENQ
Humanigen, Inc
14 Aug 23
Notice of late quarterly filing
4:05pm
unreasonable effort or expense. As a result, the Company and its independent auditor need additional time to complete certain disclosures
8-K
HGENQ
Humanigen, Inc
24 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:25pm
of a majority of independent directors; and Nasdaq Rule 5605(c)(2), which requires a Nasdaq-listed company to have an audit committee of the board of directors … comprised of at least three independent directors meeting the eligibility requirements of that Rule.
Item 5.02
Departure of Directors or Certain
8-K
EX-99.1
c7c867ne9x zkw1koyh
26 Jul 22
Humanigen Implements Strategic Realignment of Pipeline and Resources to Achieve Key Clinical Milestones
4:05pm
8-K
ow1e40amkr1k
10 Jun 22
Submission of Matters to a Vote of Security Holders
4:56pm
424B5
b2f3kcs wcupgoj
14 Apr 22
Prospectus supplement for primary offering
5:27pm
8-K
EX-10.1
cd5q6 v94e9mv5fmsihq
12 Apr 22
Other Events
4:07pm
DEFA14A
my9u shycvyv8dvx
12 Apr 22
Additional proxy soliciting materials
4:05pm
8-K
EX-99.1
8trlxe3
2 Dec 21
Other Events
8:00am